Cigna Group Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)
Latest Ratings for CI Date Firm Action From To Mar 2022 Mizuho Maintains Buy Feb 2022 SVB Leerink Maintains Market Perform Feb 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for CI View the Latest Analyst Ratings read more
What Analysts Are Saying About Bridge Investment Group Stock
Latest Ratings for BRDG Date Firm Action From To Mar 2022 Citigroup Maintains Buy Dec 2021 Citigroup Maintains Buy Aug 2021 Morgan Stanley Maintains Overweight View More Analyst Ratings for BRDG View the Latest Analyst Ratings read more
7 Analysts Have This To Say About Celldex Therapeutics
Latest Ratings for CLDX Date Firm Action From To Sep 2021 Jefferies Initiates Coverage On Buy Sep 2021 HC Wainwright & Co. Maintains Buy Sep 2021 SVB Leerink Initiates Coverage On Outperform View More Analyst Ratings for CLDX View the Latest Analyst Ratings read more
Where Allegiant Travel Stands With Analysts
Latest Ratings for ALGT Date Firm Action From To Mar 2022 Evercore ISI Group Downgrades Outperform In-Line Jan 2022 Barclays Maintains Overweight Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for ALGT View the Latest Analyst Ratings read more
Analyst Expectations For Spire’s Future
Latest Ratings for SR Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Guggenheim Downgrades Buy Neutral Jan 2022 Guggenheim Downgrades Buy Neutral View More Analyst Ratings for SR View the Latest Analyst Ratings read more
